Oxfordbiotherapeutics
This role involves overseeing the mining and annotation of proprietary proteomics datasets to identify and research candidate targets for cancer therapeutics. The position requires interfacing with commercial teams to scope analyses and deliver insights that support partnering and portfolio decisions. It emphasizes scientific leadership, strong organizational skills, and effective communication within a collaborative environment.
Headquarters
Oxford, England, United Kingdom
Company Size
11-50 employees
Founded
2004
Oxford BioTherapeutics is a biotechnology company focused on developing first‑in‑class oncology therapies. They pioneer targeted approaches including Antibody‑Drug Conjugates (ADCs), immuno‑oncology agents, T‑Cell Engagers (TCEs), and radiopharmaceuticals. The company advances a pipeline driven by translational science and strategic partnerships to accelerate delivery of novel cancer treatments to patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Oxfordbiotherapeutics.
41% below the average for this role
Bioinformatics Engineer - Proteomics
DOOR
Huck Institutes of the Life Sciences NSF NCEMS Postdoctoral Scholar-Computational Proteomics/Mass Spectrometry
pennstate.edu
Staff Scientist
University of Chicago
Research Scientist
Institute for Systems Biology (ISB)
Postdoctoral Positions
oraclecloudinfrastructure
Postdoctoral Positions
oraclecloudinfrastructure